These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11475808)

  • 21. [Evaluation of reports on "pregnancy and drugs" received during a period of 39 months by the Regional Pharmacovigilance Center, Lorraine (Nancy)].
    Hanesse B; Trechot P; el Kouch S; Pierfitte C; Royer R; Netter P
    Therapie; 1995; 50(5):471-2. PubMed ID: 8571291
    [No Abstract]   [Full Text] [Related]  

  • 22. An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy.
    McAuley JW; Chen AY; Elliott JO; Shneker BF
    Epilepsy Behav; 2009 Jan; 14(1):113-7. PubMed ID: 18768168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug vigilance].
    Imbs JL; Welsch M
    Rev Prat; 2002 Mar; 52(5):502-6. PubMed ID: 11949502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3/10 Undesirable side-effects of drugs: causes, consequences, prevention].
    Soins; 2006 Apr; (704):69-70. PubMed ID: 16704014
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primum non nocere].
    Harefuah; 1981 Nov; 101(10):282-4. PubMed ID: 7347292
    [No Abstract]   [Full Text] [Related]  

  • 26. Study finds problems with reporting side effects.
    TreatmentUpdate; 2002 Jul; 14(5):3-4. PubMed ID: 12141280
    [No Abstract]   [Full Text] [Related]  

  • 27. [Iatrogenic disease in the elderly, Health in Action wants to create a security belt around drugs].
    Maisonneuve C
    Soins Gerontol; 2004; (50):5-6. PubMed ID: 15626177
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacist's role in the prevention of adverse drug interactions.
    Dunphy TW
    Am J Hosp Pharm; 1969 Jul; 26(7):366-77. PubMed ID: 5807979
    [No Abstract]   [Full Text] [Related]  

  • 29. Rational therapeutics and iatrogeny.
    Nahum LH
    Conn Med; 1968 Apr; 32(4):250-2. PubMed ID: 5653059
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cure for iatrogenic disease: look before you leap.
    Hurwitz MM
    Geriatrics; 1973 Apr; 28(4):56 passim. PubMed ID: 4700070
    [No Abstract]   [Full Text] [Related]  

  • 33. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Need for monitoring adverse drug reactions.
    Nerurkar RP; Nadkar MY; Bichile SK
    J Assoc Physicians India; 1998 Aug; 46(8):673-4. PubMed ID: 11229269
    [No Abstract]   [Full Text] [Related]  

  • 35. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Public health. The nurse and the avoidable medication risk].
    Queneau P
    Soins; 1999 Jun; (636):50-1. PubMed ID: 10595239
    [No Abstract]   [Full Text] [Related]  

  • 39. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 40. Studying the causes of adverse drug reactions: circumvent the warning-interfered bias using the case-case comparison approach.
    Wang LY; Lee WC
    J Clin Epidemiol; 2008 May; 61(5):516. PubMed ID: 18394547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.